| Dr Eugene L Kerns, MD | |
|
2322 E Kimberly Rd, Davenport, IA 52807-7205 | |
| (563) 355-1853 | |
| (563) 355-0327 |
| Full Name | Dr Eugene L Kerns |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 2322 E Kimberly Rd, Davenport, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518931153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 19961 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eugene L Kerns, MD 2322 E Kimberly Rd, Davenport, IA 52807-7205 Ph: (563) 355-1853 | Dr Eugene L Kerns, MD 2322 E Kimberly Rd, Davenport, IA 52807-7205 Ph: (563) 355-1853 |
News Archive
Randomised Controlled Trials (RCTs) are considered the 'gold standard' research method for assessing new medical treatments. But research published in BioMed Central's open access journal Trials shows that the design of a remarkable 93 percent of 2235 so-called RCTs published in some Chinese medical journals during 1994 to 2005 was flawed, casting doubt on the reliability of research that is likely to influence medical decision-makers.
For most adolescents, playing video games is an enjoyable and often social form of entertainment. While playing video games is a fun pastime, there is a growing concern that spending too much time playing video games is related to negative developmental outcomes and can become an addiction.
Illumina, Inc. today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeq NIPT Analysis Software for clinical laboratories in the European Union (EU).
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
› Verified 9 days ago
Dr. Harold L Mihm, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2322 E Kimberly Rd, Suite 30w, Davenport, IA 52807 Phone: 563-355-1853 Fax: 563-359-1512 | |
Clare Bevin Harney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1510 E Rusholme St, Davenport, IA 52803 Phone: 563-336-3000 | |
Jana Van Rybroek, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5350 Eastern Ave, Davenport, IA 52807 Phone: 563-355-1853 | |
Paul K H Figge Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3400 Dexter Ct, Ste 100, Davenport, IA 52807 Phone: 563-355-2244 Fax: 563-344-6701 | |
Dr. Jennifer Christine Steines Wagemester, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5350 Eastern Ave, Davenport, IA 52807 Phone: 563-355-1853 Fax: 563-359-1512 | |
Johanna B Whalen, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1230 E Rusholme St, Ste 301, Davenport, IA 52803 Phone: 563-322-9150 Fax: 563-322-9148 |